# Everus Construction Group, Inc.: overview

ECG · NYSE · CIK 2015845 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ecg.md) · [Financials](/companies/ecg/financials.md) · [Filings](/companies/ecg/filings.md) · [Insiders](/companies/ecg/insiders.md)

Latest reported revenue: [$1.23bn](/filings/0002015845-26-000050.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0002015845-26-000050).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [761](/filings/0002015845-25-000083.md) | [760 d](/filings/0002015845-26-000010.md) | [827](/filings/0002015845-26-000030.md) | [921](/filings/0002015845-26-000050.md) | [987](/filings/0002015845-25-000083.md) | [1,011 d](/filings/0002015845-26-000010.md) | [1,037](/filings/0002015845-26-000030.md) | [1,232](/filings/0002015845-26-000050.md) |
| Gross margin | % | [11.8%](/filings/0002015845-25-000083.md) | [11.4% d](/filings/0002015845-26-000010.md) | [11.2%](/filings/0002015845-26-000030.md) | [13.0%](/filings/0002015845-26-000050.md) | [12.6%](/filings/0002015845-25-000083.md) | [11.6% d](/filings/0002015845-26-000010.md) | [12.6%](/filings/0002015845-26-000030.md) | [14.9%](/filings/0002015845-26-000050.md) |
| Operating margin | % | [7.1%](/filings/0002015845-25-000083.md) | [6.1% d](/filings/0002015845-26-000010.md) | [6.2%](/filings/0002015845-26-000030.md) | [7.9%](/filings/0002015845-26-000050.md) | [7.3%](/filings/0002015845-25-000083.md) | [6.8% d](/filings/0002015845-26-000010.md) | [7.5%](/filings/0002015845-26-000030.md) | [9.1%](/filings/0002015845-26-000050.md) |
| Net margin | % | [5.5%](/filings/0002015845-25-000083.md) | [4.5% d](/filings/0002015845-26-000010.md) | [4.4%](/filings/0002015845-26-000050.md) | [5.7%](/filings/0002015845-26-000050.md) | [5.8%](/filings/0002015845-25-000083.md) | [5.5% d](/filings/0002015845-26-000010.md) | [5.6%](/filings/0002015845-26-000050.md) | [6.8%](/filings/0002015845-26-000050.md) |
| Diluted EPS | $ per share | [0.82](/filings/0002015845-25-000083.md) | not reported | [0.72](/filings/0002015845-26-000030.md) | [1.03](/filings/0002015845-26-000050.md) | [1.11](/filings/0002015845-25-000083.md) | not reported | [1.14](/filings/0002015845-26-000030.md) | [1.64](/filings/0002015845-26-000050.md) |
| Free cash flow | $m | [60.9 d](/filings/0002015845-25-000083.md) | [66.9 d](/filings/0002015845-26-000010.md) | [(11.4)](/filings/0002015845-26-000030.md) | [12.3 d](/filings/0002015845-26-000050.md) | [65.7 d](/filings/0002015845-25-000083.md) | [23.5 d](/filings/0002015845-26-000010.md) | [128](/filings/0002015845-26-000030.md) | [33.0 d](/filings/0002015845-26-000050.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,699](/filings/0002015845-25-000012.md) | [2,854](/filings/0002015845-26-000010.md) | [2,850](/filings/0002015845-26-000010.md) | [3,746](/filings/0002015845-26-000010.md) |
| Gross margin | % | [10.2%](/filings/0002015845-25-000012.md) | [11.3%](/filings/0002015845-26-000010.md) | [11.9%](/filings/0002015845-26-000010.md) | [12.1%](/filings/0002015845-26-000010.md) |
| Operating margin | % | [6.1%](/filings/0002015845-25-000012.md) | [6.7%](/filings/0002015845-26-000010.md) | [6.7%](/filings/0002015845-26-000010.md) | [7.1%](/filings/0002015845-26-000010.md) |
| Net margin | % | [4.6%](/filings/0002015845-25-000012.md) | [4.8%](/filings/0002015845-26-000010.md) | [5.0%](/filings/0002015845-26-000010.md) | [5.4%](/filings/0002015845-26-000010.md) |
| Diluted EPS | $ per share | [2.45](/filings/0002015845-25-000012.md) | [2.69](/filings/0002015845-26-000010.md) | [2.81](/filings/0002015845-26-000010.md) | [3.95](/filings/0002015845-26-000010.md) |
| Free cash flow | $m | [(61.3)](/filings/0002015845-25-000012.md) | [136](/filings/0002015845-26-000010.md) | [115](/filings/0002015845-26-000010.md) | [90.0](/filings/0002015845-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ecg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.09bn | 6,593,812 |  | Added +502,887 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $437.9m | 2,638,646 |  | Added +57,081 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $382.5m | 2,304,744 |  | Added +13,819 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $281.1m | 1,693,806 |  | Added +76,478 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $260.5m | 1,569,546 |  | Added +612,940 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $241.7m | 1,455,926 |  | Added +280,236 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $198.6m | 1,196,538 |  | Reduced −1,820,711 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $182.5m | 1,099,806 |  | Reduced −14,805 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $173.9m | 1,048,171 |  | Reduced −56,885 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $170.7m | 1,028,743 |  | Added +414,431 |

## Recent filings

[All 142 filings](/companies/ecg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 16:08 ET | [8-K](/filings/0002015845-26-000056.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0002015845-26-000056 |
| 2026-09-02 | 19:18 ET | [8-K](/filings/0002015845-26-000053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002015845-26-000053 |
| 2026-08-05 | 16:49 ET | [10-Q](/filings/0002015845-26-000050.md) | Quarterly report, period 2026-06-30 | 0002015845-26-000050 |
| 2026-08-04 | 16:31 ET | [8-K](/filings/0002015845-26-000047.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002015845-26-000047 |
| 2026-07-31 | 08:32 ET | [8-K](/filings/0002015845-26-000042.md) | 7.01 Regulation FD disclosure | 0002015845-26-000042 |
| 2026-05-14 | 16:21 ET | [8-K](/filings/0002015845-26-000033.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0002015845-26-000033 |
| 2026-05-06 | 16:42 ET | [10-Q](/filings/0002015845-26-000030.md) | Quarterly report, period 2026-03-31 | 0002015845-26-000030 |
| 2026-05-05 | 16:33 ET | [8-K](/filings/0002015845-26-000027.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002015845-26-000027 |
| 2026-04-02 | 08:19 ET | [8-K](/filings/0002015845-26-000023.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002015845-26-000023 |
| 2026-03-27 | 08:20 ET | [DEF 14A](/filings/0002015845-26-000019.md) | Proxy statement, period 2026-05-12 | 0002015845-26-000019 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0002015845-26-000010.md), filed Feb 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/4a1742aa-8e89-4d39-ae04-5e6cb7ee480a)

## About the filer

- CIK: 2015845
- Tickers: ECG
- Exchange: NYSE
- SIC code: 1531 Operative Builders
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.